9 results on '"Pasquale Malandrino"'
Search Results
2. Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask
- Author
-
Manuela Albertelli, Federica Grillo, Fabio Lo Calzo, Giulia Puliani, Carmen Rainone, Annamaria Anita Livia Colao, Antongiulio Faggiano, NIKE group, Barbara Altieri, Luigi Barrea, Filomena Bottiglieri, Severo Campione, Federica De Cicco, Sergio Di Molfetta, Alessandra Dicitore, Carlotta Dolci, Tiziana Feola, Giuseppe Fanciulli, Diego Ferone, Francesco Ferraù, Marco Gallo, Elisa Giannetta, Erika Grossrubatscher, Elia Guadagno, Valentina Guarnotta, Andrea M. Isidori, Andrea Lania, Andrea Lenzi, Pasquale Malandrino, Erika Messina, Roberta Modica, Giovanna Muscogiuri, Luca Pes, Genoveffa Pizza, Riccardo Pofi, Paola Razzore, Laura Rizza, Manila Rubino, Rosa Maria Ruggieri, Emilia Sbardella, Franz Sesti, Mary Anna Venneri, Giovanni Vitale, and Maria Chiara Zatelli
- Subjects
neuroendocrine neoplasms (NENs) ,neuroendocrine classification ,immunohistochemistry ,pathology ,morphology ,grade ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
During the 5th NIKE (Neuroendocrine tumors Innovation in Knowledge and Education) meeting, held in Naples, Italy, in May 2019, discussions centered on the understanding of pathology reports of gastroenetropancreactic neuroendocrine neoplasms. In particular, the main problem concerned the difficulty that clinicians experience in extrapolating relevant information from neuroendocrine tumor pathology reports. During the meeting, participants were asked to identify and rate issues which they have encountered, for which the input of an expert pathologist would have been appreciated. This article is a collection of the most rated questions and relative answers, focusing on three main topics: 1) morphology and classification; 2) Ki67 and grading; 3) immunohistochemistry. Patient management should be based on multidisciplinary decisions, taking into account clinical and pathology-related features with clear comprehension between all health care professionals. Indeed, pathologists require clinical details and laboratory findings when relevant, while clinicians require concise and standardized reports. In keeping with this last statement, the minimum requirements in pathology datasets are provided in this paper and should be a baseline for all neuroendocrine tumor professionals.
- Published
- 2021
- Full Text
- View/download PDF
3. Nandrolone Decanoate: Use, Abuse and Side Effects
- Author
-
Federico Giuseppe Patanè, Aldo Liberto, Andreana Nicoletta Maria Maglitto, Pasquale Malandrino, Massimiliano Esposito, Francesco Amico, Giuseppe Cocimano, Giuseppe Li Rosi, Dario Condorelli, Nunzio Di Nunno, and Angelo Montana
- Subjects
nandrolone decanoate ,drug abuse ,androgenic steroids ,adverse effects ,steroid treatment ,Medicine (General) ,R5-920 - Abstract
Background and Objectives: Androgens play a significant role in the development of male reproductive organs. The clinical use of synthetic testosterone derivatives, such as nandrolone, is focused on maximizing the anabolic effects and minimizing the androgenic ones. Class II anabolic androgenic steroids (AAS), including nandrolone, are rapidly becoming a widespread group of drugs used both clinically and illicitly. The illicit use of AAS is diffused among adolescent and bodybuilders because of their anabolic proprieties and their capacity to increase tolerance to exercise. This systematic review aims to focus on side effects related to illicit AAS abuse, evaluating the scientific literature in order to underline the most frequent side effects on AAS abusers’ bodies. Materials and Methods: A systematic review of the scientific literature was performed using the PubMed database and the keywords “nandrolone decanoate”. The inclusion criteria for articles or abstracts were English language and the presence of the following words: “abuse” or “adverse effects”. After applying the exclusion and inclusion criteria, from a total of 766 articles, only 148 were considered eligible for the study. Results: The most reported adverse effects (found in more than 5% of the studies) were endocrine effects (18 studies, 42%), such as virilization, gynecomastia, hormonal disorders, dyslipidemia, genital alterations, and infertility; cardiovascular dysfunctions (six studies, 14%) such as vascular damage, coagulation disorders, and arteriosus hypertension; skin disorders (five studies, 12%) such as pricking, acne, and skin spots; psychiatric and mood disorders (four studies, 9%) such as aggressiveness, sleep disorders and anxiety; musculoskeletal disorders (two studies, 5%), excretory disorders (two studies, 5%), and gastrointestinal disorders (two studies, 5%). Conclusions: Based on the result of our study, the most common adverse effects secondary to the abuse of nandrolone decanoate (ND) involve the endocrine, cardiovascular, skin, and psychiatric systems. These data could prove useful to healthcare professionals in both sports and clinical settings.
- Published
- 2020
- Full Text
- View/download PDF
4. Catheter-related Bloodstream Infections: A Root Cause Analysis in a Series of Simultaneous Ochrobactrum anthropi Infections
- Author
-
Pietrantonio Ricci, Dario Condorelli, Aniello Maiese, Federico Giuseppe Patanè, Giulio Di Mizio, Diego Geraci, Aldo Liberto, Filomena Casella, Benedetto Caroleo, and Pasquale Malandrino
- Subjects
Male ,0301 basic medicine ,Clinical audit ,Catheter Insertion Site ,medicine.medical_specialty ,Ochrobactrum anthropi ,030106 microbiology ,Pharmaceutical Science ,Bacteremia ,03 medical and health sciences ,Patient safety ,ochrobactrum anthropi ,0302 clinical medicine ,prevention ,chemotherapy treatment immunocompromised patients ,clinical risk management ,medicine ,Humans ,Infection control ,030212 general & internal medicine ,Intensive care medicine ,Aged ,biology ,catheter-related infection ,hospital acquired infections (HAIs) ,root cause analysis process ,business.industry ,Middle Aged ,biology.organism_classification ,Anti-Bacterial Agents ,Catheter ,Catheter-Related Infections ,Practice Guidelines as Topic ,Female ,Root Cause Analysis ,Gram-Negative Bacterial Infections ,business ,Root cause analysis ,Biotechnology ,Healthcare system - Abstract
Objective:Catheter-related bloodstream infections (CRBSIs) pathogenesis is complex and multifactorial mostly due to cutaneous microorganisms migration through the catheter insertion site and catheter tip colonization. Ochrobactrum anthropi is a gram-negative bacterium belonging to the Brucellaceae and related infections are especially observed in immunocompromised patients.Methods:Therefore, O. anthropi infection prevention and surveillance are relevant issues for healthcare system and risk management, in order to improve healthcare quality and patient safety. Four cases of anthropi-related CRBSIs occurring in immunodepressed patients under chemotherapy treatment are reported and the possible prevention and surveillance strategies are analyzed.Results:In the reported cases, all infections occurred almost simultaneously in the Oncology Unit, leading to hypothesize an identical infection source. Subsequently, a clinical audit was performed in order to investigate infection origin and implement prevention and control strategies. Clinical audit allowed to identify the hand hygiene defects as the primary source of the infections, responsible for catheter flushing solution contamination.Conclusion:The aim of this study is to reveal how through correct root cause analysis and clinical audit, several measures could be undertaken in order to promote the prevention of the CRBSIs risk
- Published
- 2019
- Full Text
- View/download PDF
5. Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management
- Author
-
Giuseppe Fanciulli, Sergio Di Molfetta, Andrea Dotto, Tullio Florio, Tiziana Feola, Annamaria Colao, Antongiulio Faggiano, NIKE Group, Manuela Albertelli, Barbara Altieri, Luigi Barrea, Filomena Bottiglieri, Severo Campione, Federica de Cicco, Alessandra Dicitore, Diego Ferone, Francesco Ferraù, Erika Grossrubatscher, Marco Gallo, Elisa Giannetta, Federica Grillo, Elia Guadagno, Valentina Guarnotta, Andrea M. Isidori, Andrea Lania, Andrea Lenzi, Fabio Lo Calzo, Pasquale Malandrino, Erika Messina, Roberta Modica, Giovanna Muscogiuri, Genoveffa Pizza, Riccardo Pofi, Giulia Puliani, Carmen Rainone, Paola Razzore, Laura Rizza, Manila Rubino, Rosa Maria Ruggieri, Emilia Sbardella, Franz Sesti, Mary Anna Venneri, Giovanni Vitale, Maria Chiara Zatelli, Fanciulli, G., Di Molfetta, S., Dotto, A., Florio, T., Feola, T., Colao, A., and Faggiano, A.
- Subjects
Oncology ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Immune checkpoint inhibitors ,immune checkpoint inhibitor ,Ipilimumab ,Pembrolizumab ,Diseases of the endocrine glands. Clinical endocrinology ,immune checkpoint inhibitors ,Antineoplastic Agents, Immunological ,Endocrinology ,Internal medicine ,medicine ,antineoplastic agents ,Humans ,ipilimumab ,Lymph node ,nivolumab ,business.industry ,General Commentary ,Lymph Node ,Lymphatic Metastasi ,parathyroid carcinoma ,medicine.disease ,RC648-665 ,immunological ,medicine.anatomical_structure ,Parathyroid Neoplasms ,Parathyroid carcinoma ,Lymphatic Metastasis ,pembrolizumab ,Lymph Nodes ,Nivolumab ,business ,humans ,lymph nodes ,lymphatic metastasis ,antineoplastic agents, immunological ,parathyroid neoplasms ,medicine.drug ,Human - Published
- 2021
6. Nandrolone Decanoate: Use, Abuse and Side Effects
- Author
-
Pasquale Malandrino, Giuseppe Cocimano, Dario Condorelli, Giuseppe Li Rosi, Angelo Montana, Nunzio Di Nunno, Andreana Nicoletta Maria Maglitto, Federico Giuseppe Patanè, Aldo Liberto, Massimiliano Esposito, Francesco Amico, Patane, F. G., Liberto, A., Maglitto, A. N. M., Malandrino, P., Esposito, M., Amico, F., Cocimano, G., Rosi, G. L., Condorelli, D., Di Nunno, N., and Montana, A.
- Subjects
Male ,Medicine (General) ,medicine.medical_specialty ,Adolescent ,Nandrolone decanoate ,Review ,Adverse effect ,Drug abuse ,R5-920 ,Steroid treatment ,Anabolic Agents ,Androgenic steroid ,Internal medicine ,medicine ,Humans ,Nandrolone ,Exercise ,Acne ,drug abuse ,nandrolone decanoate ,business.industry ,Testosterone (patch) ,General Medicine ,medicine.disease ,Substance abuse ,Mood disorders ,Androgens ,adverse effects ,Anxiety ,medicine.symptom ,androgenic steroids ,business ,Dyslipidemia ,steroid treatment ,medicine.drug - Abstract
Background and Objectives: Androgens play a significant role in the development of male reproductive organs. The clinical use of synthetic testosterone derivatives, such as nandrolone, is focused on maximizing the anabolic effects and minimizing the androgenic ones. Class II anabolic androgenic steroids (AAS), including nandrolone, are rapidly becoming a widespread group of drugs used both clinically and illicitly. The illicit use of AAS is diffused among adolescent and bodybuilders because of their anabolic proprieties and their capacity to increase tolerance to exercise. This systematic review aims to focus on side effects related to illicit AAS abuse, evaluating the scientific literature in order to underline the most frequent side effects on AAS abusers’ bodies. Materials and Methods: A systematic review of the scientific literature was performed using the PubMed database and the keywords “nandrolone decanoate”. The inclusion criteria for articles or abstracts were English language and the presence of the following words: “abuse” or “adverse effects”. After applying the exclusion and inclusion criteria, from a total of 766 articles, only 148 were considered eligible for the study. Results: The most reported adverse effects (found in more than 5% of the studies) were endocrine effects (18 studies, 42%), such as virilization, gynecomastia, hormonal disorders, dyslipidemia, genital alterations, and infertility; cardiovascular dysfunctions (six studies, 14%) such as vascular damage, coagulation disorders, and arteriosus hypertension; skin disorders (five studies, 12%) such as pricking, acne, and skin spots; psychiatric and mood disorders (four studies, 9%) such as aggressiveness, sleep disorders and anxiety; musculoskeletal disorders (two studies, 5%), excretory disorders (two studies, 5%), and gastrointestinal disorders (two studies, 5%). Conclusions: Based on the result of our study, the most common adverse effects secondary to the abuse of nandrolone decanoate (ND) involve the endocrine, cardiovascular, skin, and psychiatric systems. These data could prove useful to healthcare professionals in both sports and clinical settings.
- Published
- 2020
7. From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?
- Author
-
Giulia Puliani, Andrea Lania, Fabio Lo Calzo, Valentina Guarnotta, Giuseppe Fanciulli, Alessandra Dicitore, Carmen Rainone, Annamaria Colao, Genoveffa Pizza, Manila Rubino, Giovanni Vitale, Severo Campione, Francesco Ferraù, Maria Chiara Zatelli, Mary Anna Venneri, Emilia Sbardella, Diego Ferone, Marco Gallo, Riccardo Pofi, Roberta Modica, Luigi Barrea, Erika Grossrubatscher, Federica Grillo, Antongiulio Faggiano, Franz Sesti, Rosa Maria Ruggieri, Barbara Altieri, Erika Messina, Luca Pes, P. Razzore, Nike, Andrea M. Isidori, Sergio Di Molfetta, Pasquale Malandrino, Andrea Lenzi, Manuela Albertelli, Tiziana Feola, Laura Rizza, Giovanna Muscogiuri, Federica de Cicco, Filomena Bottiglieri, Elia Guadagno, Elisa Giannetta, Vitale G, Dicitore A, Barrea L, Sbardella E, Razzore P, Campione S, Faggiano A, Colao A, NIKE, Albertelli M, Altieri B, Bottiglieri F, De Cicco F, Di Molfetta S, Fanciulli G, Feola T, Ferone D, Ferraù F, Gallo M, Giannetta E, Grillo F, Grossrubatscher E, Guadagno E, Guarnotta V, Isidori AM, Lania A, Lenzi A, Calzo FL, Malandrino P, Messina E, Modica R, Muscogiuri G, Pes L, Pizza G, Pofi R, Puliani G, Rainone C, Rizza L, Rubino M, Ruggieri RM, Sesti F, Venneri MA, Zatelli MC., Vitale, G., Dicitore, A., Barrea, L., Sbardella, E., Razzore, P., Campione, S., Faggiano, A., Colao, A., Albertelli, M., Altieri, B., Bottiglieri, F., De Cicco, F., Di Molfetta, S., Fanciulli, G., Feola, T., Ferone, D., Ferrau, F., Gallo, M., Giannetta, E., Grillo, F., Grossrubatscher, E., Guadagno, E., Guarnotta, V., Isidori, A. M., Lania, A., Lenzi, A., Calzo, F. L., Malandrino, P., Messina, E., Modica, R., Muscogiuri, G., Pes, L., Pizza, G., Pofi, R., Puliani, G., Rainone, C., Rizza, L., Rubino, M., Ruggieri, R. M., Sesti, F., Venneri, M. A., and Zatelli, M. C.
- Subjects
Endocrinology, Diabetes and Metabolism ,Tumor microenvironment ,Biology ,Gut flora ,Neuroendocrine tumors ,medicine.disease_cause ,digestive system ,Article ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Immune system ,Neuroendocrine tumor ,Gastro ,medicine ,Humans ,Cytokine ,030304 developmental biology ,Gastrointestinal Neoplasms ,Inflammation ,0303 health sciences ,Microbiota ,digestive, oral, and skin physiology ,medicine.disease ,biology.organism_classification ,Cytokines ,Gastrointestinal Microbiome ,030220 oncology & carcinogenesis ,Immunology ,Dysbiosis ,Carcinogenesis ,Drug metabolism - Abstract
Gut microbiota is represented by different microorganisms that colonize the intestinal tract, mostly the large intestine, such as bacteria, fungi, archaea and viruses. The gut microbial balance has a key role in several functions. It modulates the host’s metabolism, maintains the gut barrier integrity, participates in the xenobiotics and drug metabolism, and acts as protection against gastro-intestinal pathogens through the host’s immune system modulation. The impaired gut microbiota, called dysbiosis, may be the result of an imbalance in this equilibrium and is linked with different diseases, including cancer. While most of the studies have focused on the association between microbiota and gastrointestinal adenocarcinomas, very little is known about gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs). In this review, we provide an overview concerning the complex interplay between gut microbiota and GEP NENs, focusing on the potential role in tumorigenesis and progression in these tumors.
- Published
- 2020
8. Shallow-water blackout: a rare case of death during pool free diving
- Author
-
Liberto, Aldo, Fichera, Martina, Pasquale, Malandrino, Condorelli, C., Cocicamano, G, Cascio, Orazio, Edmondo, Scoto, Salerno, Monica, Angelo, Montana, and di mizio, G.
- Published
- 2020
9. RAI Refractory Differentiated Thyroid Cancer Treated with Lenvatinib: Case Report
- Author
-
Ivana Puliafito, Angela Prestifilippo, Caterina Puglisi, Francesca Esposito, Pasquale Malandrino, Stefania Marchisotta, P. Giuffrida, and Dario Giuffrida
- Subjects
medicine.medical_specialty ,Lung ,business.industry ,Thyroid ,medicine.disease ,Papillary thyroid cancer ,Thyroid carcinoma ,chemistry.chemical_compound ,medicine.anatomical_structure ,chemistry ,medicine ,Choroid ,Radiology ,Progression-free survival ,business ,Lenvatinib ,Thyroid cancer - Abstract
Background: Differentiated thyroid carcinoma (DTC) is the most common malignant tumor of the thyroid gland and causes local and/or distant metastases. Differentiated thyroid carcinoma (DTC) is the most common form, representing more than 90% of all thyroid cancers and derives from the follicular cells of the thyroid. Choroidal metastasis from DTC is extremely rare. Only a few cases have been reported in literature. Case Summary: We report the case of a 43-year-old man with differentiated thyroid cancer. He underwent a total thyroidectomy plus a right latero-cervical lymphoadenectomy. Histological examination revealed a 7 mm papillary thyroid cancer, pT3N1b. Firstly treated with locoregional treatment. In February 2012 computer tomography (CT) scan and WBS showed a progression of disease with bilateral lung lesions, bilateral multiple jugular carotid lymphnodes and bone metastases localized in the IV thoracic rib. After progression disease he was treated with Lenvatinib 24 mg daily. Symptomatic choroid metastases were diagnosed 4 years after initial diagnosis, and were treated with external-beam radiation. Although treatment reduced local masses, a rapid progression of multiple metastatic lesions was observed. Conclusion: In our case, progression free survival with lenvatinib was in agreement with data of SELECT trial, this is a rare case of choroidal metastases from DTC.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.